History of the Future as seen by Professor A Dayan
My role in what became HET arose from discussions in the late 1980s between the British Toxicology Society and Stockton Press and the late Professor Paul Turner, the publisher and the Editor of what was then`Human Toxicology'. HT had been running successfully for almost 10 years focused on investigative studies and reports of toxicity in humans. It seemed appropriate to us all to extend its remit to cover the considerable advances in other areas of toxicology and the sciences that it uses. The result was`Human and Experimental Toxicology', a journal that has worked hard to span the range of interests from the molecular to man and from the chemical to the clinical. How well we have succeeded only our readers will know but much effort has gone into stimulating and welcoming work that deliberately encompasses the widest range of`toxicity' whether done in the laboratory, in the hospital, by the epidemiologists or, at the apex of much of our discipline, as the assessment and control of risk.
If you look at the history of`Toxicology' as a profession and as an academic discipline, you will ®nd that it has come from the laboratory of chemists, pharmacologists and biochemists, from the medical and forensic work of physicians, and increasingly from the need of governments and the governed to detect and assess risks so that they can be controlled. At present, perhaps we are still enthralled by the knowledge that biochemistry and molecular biology can bring, we tend to neglect the disorders of function that belong more to the pharmacologist and physiologist, immunology and the behavioural sciences have yet to make their full impact, and medicine, like pathology, often tends to be regarded as someone else's subject. I am unashamed holist, as I ®rmly believe that the toxicologist must be ready to use any science to detect and investigate problems, and be prepared to deploy and bene®t from any sort of knowledge in understanding what makes a chemical risk and how to deal with it.
You may feel that this will result in diffuseness, lack of focus and intellectual weakness. I argue to the contrary that it strengthens toxicology if it is possible to study a problem or an effect and to be able to move from, say, a disturbance of health in someone or even in some population, through dysfunction to structural lesion and then to the intimate cellular or even biochemical mechanism. It may be hard work, but it is fun to try to span these disparate areas.
I have always hoped and tried to make HET a vehicle for such a breadth of knowledge, alerting the expert to the novel and guiding the generalist into appreciation of the narrower depths of the specialist. That may not be a fashionable view but I believe it is the future of our discipline.
My work for HET has never been less than intriguing and often it has been fascinating. None of it could have been done without the help of others. I, like you, the reader, owe much to the skills and patient help of the Deputy Editor, Alan Paine, co-editors ± Karl Bock, Wolfgang Forth and Wally Hayes, and the members of the Editorial Board ± and especially the almost unseen but vital reviewers. Another unrealised but essential set of skills is that of the publisher, whom the reader never sees, but on whom editors are totally dependent. At last I can saỳ Thank you' publicly to all those who have encouraged and helped so far, and ask that you do no less for my successor Robert Kroes.
Antony Dayan
Comments from Professor R Kroes
Firstly I would like to say thank you Tony, for the extremely effective and successful work you have performed for HET. I believe your words re¯ect very well the feelings of today's toxicologists. Toxicology is undoubtedly a multidisciplinary science and the input of many disciplines is required to assess risks appropriately. Mechanistic information and the use of models to mimic kinetics and dynamics of substances of concern together with basic and classical information are necessary to complete one part of the risk assessment scheme and to perform appropriate effect assessment for humans and animals.
The combination of clinical toxicology and experimental toxicology provides the ideal input for the risk assessor. In addition, increasing attention for in vitro toxicology can be expected since it may successfully complete our insight in toxicological mechanisms. HET will focus increasingly on elements that facilitate (quantitative) risk assessment, whether this is in the clinical ®eld or focused on preventive measures to be taken to safely use chemicals in the broadest sense for the bene®t of man.
We will try to continue the excellent work of Professor Dayan and will follow his ideas into making HET the bridge between the basic scientist and the general toxicologist, as well as between the risk assessor and the risk manager. This can only be done with the constructive help of the Editorial Board, the reviewers and the input of all those scientists willing to publish their ®ndings in HET. With the assistance of Wally Hayes in the Americas, we the Editors shall endeavor to maintain and indeed improve upon the rapid processing of submitted articles. Let us get back to work now and let you the reader be the judge! Robert Kroes Editorial
